ASH 50th (2008)

Title Content type
Primary Prophylaxis against Invasive Fungal Infections (IFI) with Posaconazole (POS) or Voriconazole (VRC) Shows Better Efficacy Compared to No Systemic Prophylaxis during Induction and Consolidation Chemotherapy Cycles of Adult Acute Leukemia Patients (click for details)
First Line Treatment of Probable and Proven Invasive Aspergillosis with Caspofungin in Oncohemopatic Patients. A Single Centre Experience (click for details)
GRASPALL 2005.01 Clinical Study: L-Asparaginase Loaded into Red Blood Cells Is Effective at Depleting Serum Asparagine in Children and Adults with Relapsed Acute Lymphoblastic Leukaemia (ALL) (click for details)
Relaxing the Protected Environment Has Not Adversely Impacted Early Outcome of Older Patients ( 50 years) with AML and HR- MDS Receiving Induction Therapy (click for details)
Conditioning without Antibiotic Prophylaxis May Not Increase Infection Related Mortality in Allogeneic Hematopoeitic Stem Cell Transplantation (click for details)
Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Preliminary Results of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324). (click for details)
Voriconazole for Secondary Prophylaxis of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Recipients: Results of the VOSIFI Study. on Behalf of the VOSIFI Study Group and the Infectious Diseases Working Party of the European Bone and Marrow T (click for details)
Clinical Outcome of Aspergillus-Specific Cytotoxic T Lymphocytes for Refractory Invasive Aspergillosis in Patients with Hematological Malignancies. (click for details)
Candidemia in Patients with Hematological Malignancies: The Role of Prophilaxis and the Importance of Local Epidemiology for Treatment (click for details)
Posaconazole as Prophylaxis in Immunocompromised Patients: A Single Center Experience (click for details)

Pages

Subscribe to ASH 50th (2008)